Although a few of pediatric gliomas share these molecular features with GNT3,5,10, CD34 expression and BRAFV600E mutation, as an adjunct diagnostic marker, are routinely screened in the diagnosis of GNT5–7. This evidence concerns the gene MGAT3 and central nervous system cancer.